Ixekizumab, CAS 1143503-69-8

Product Description: Ixekizumab (LY2439821) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A (KD[1][2].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Liu L, et al. Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A. J Inflamm Res. 2016;9:39-50. Published 2016 Apr 19./[2]Griffiths CE, et al. Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials. Lancet. 2015;386(9993):541-551.

CAS Number: 1143503-69-8

Molecular Weight: N/A

Compound Purity: 98.90

Research Area: Inflammation/Immunology

Solubility: H2O

Target: Interleukin Related

• SKU: MEXHY-P9924-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P9924-5
• Green Labware: No
• Package Unit: 5 mg
• Quantity Unit: STK